The Modern Pharmacy Laboratory Series, Part 2 Essentials of Pharmaceutical Compounding is organized by ContinuingEducation.com - OnCourse Learning Corporation and will be held during Mar 31, 2017 - Mar 31, 2020.
The target audience for this medical event is pharmacists. This CME Conference has been approved for a maximum of 3.00 Contact Hours.
Course Description :
In December of 2014, 14 employees, including pharmacists and co-founders, of the New England Compounding Center were arrested and charged with second-degree murder due to a deadly outbreak of meningitis caused by contaminated compounds. This devastating event resulted in dozens of deaths and illness in hundreds of others. Pharmacy law in the state of Massachusetts has since adapted a requirement specific to compounding for pharmacists and technicians but the repercussions of this event resonate deeply with providers and patients alike everywhere. This module is designed to review key fundamental concepts and principles of modern pharmacy compounding.
Conference Objectives are :
The goal of this webinar is to engage members of the interprofessional healthcare team in detecting, reporting, and preventing medication errors. By participating in an active discussion of various types of errors from different healthcare settings, participants will be able to better understand how their roles interplay in the medication use process and gain foresight into where and how errors may occur. After studying the information presented here, you will be able to:
• Identify the governing agencies and professional organizations responsible for regulating and creating standards of practice for compounding medications
• Differentiate between products that require non-sterile vs. sterile compounding preparation
• Define key compounding abbreviations, terms, and phrases related to pharmaceutical compounding via the United States Pharmacopeia (USP)
• Review key guidelines for non-sterile compounding from the United States Pharmacopeia Compendium (USPC) Chapter 795
• Review key USPC Chapter 797 guidelines for sterile compounding
• Identify commonly used equipment used in non-sterile vs. sterile compounding
• Define and differentiate between the risk levels involved in compounding non-sterile vs. sterile products
• Review the main responsibilities of compounding personnel in the preparation of compounded products
• Implement a quality assurance program to ensure patient safety with regards to compounded medications
Pharmacy and Medicine